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Comparative analysis of Klebsiella pneumoniae
genomes identifies a phospholipase D family
protein as a novel virulence factor
Letícia MS Lery1,2,10*, Lionel Frangeul3, Anna Tomas4,5, Virginie Passet6,7, Ana S Almeida1,2,11, Suzanne Bialek-Davenet6,7,
Valérie Barbe8, José A Bengoechea4,5,12, Philippe Sansonetti1,2,9, Sylvain Brisse6,7 and Régis Tournebize1,2,13*
Abstract
Background: Klebsiella pneumoniae strains are pathogenic to animals and humans, in which they are both a frequent
cause of nosocomial infections and a re-emerging cause of severe community-acquired infections. K. pneumoniae
isolates of the capsular serotype K2 are among the most virulent. In order to identify novel putative virulence factors
that may account for the severity of K2 infections, the genome sequence of the K2 reference strain Kp52.145 was
determined and compared to two K1 and K2 strains of low virulence and to the reference strains MGH 78578 and
NTUH-K2044.
Results: In addition to diverse functions related to host colonization and virulence encoded in genomic regions
common to the four strains, four genomic islands specific for Kp52.145 were identified. These regions encoded genes
for the synthesis of colibactin toxin, a putative cytotoxin outer membrane protein, secretion systems, nucleases and
eukaryotic-like proteins. In addition, an insertion within a type VI secretion system locus included sel1 domain
containing proteins and a phospholipase D family protein (PLD1). The pld1 mutant was avirulent in a pneumonia
model in mouse. The pld1 mRNA was expressed in vivo and the pld1 gene was associated with K. pneumoniae isolates
from severe infections. Analysis of lipid composition of a defective E. coli strain complemented with pld1 suggests an
involvement of PLD1 in cardiolipin metabolism.
Conclusions: Determination of the complete genome of the K2 reference strain identified several genomic islands
comprising putative elements of pathogenicity. The role of PLD1 in pathogenesis was demonstrated for the first time
and suggests that lipid metabolism is a novel virulence mechanism of K. pneumoniae.
Keywords: Genome sequencing, Host-microbe interactions, Bacterial pathogenesis, Lipid metabolism
Background
Klebsiella pneumoniae is responsible for a variety of dis-
eases in humans and animals. As a prominent nosocomial
pathogen it is mainly responsible for urinary tract, respira-
tory tract or blood infections [1-3]. In addition, because of
the acquisition of extended-spectrum β-lactamases and car-
bapenemases, such as the recently described NDM-1 [4],
multi, extremely or pan-drug resistant clinical strains are
more frequently isolated [5,6]. In addition, K. pneumoniae
has re-emerged as a cause of community-acquired in-
fections including pneumonia and the characteristic
syndrome of pyogenic liver abscess, with possible compli-
cations including endophthalmitis or meningitis [7,8].
K. pneumoniae is, thus, an important virulent pathogen
able to cause serious infections in ambulatory, otherwise
healthy hosts and to spread within patients [5,9] that re-
quires a better understanding of the molecular mecha-
nisms underlying the various forms of its pathogenesis.
Major K. pneumoniae virulence factors include the
capsule, the lipopolysaccharide, iron scavenging systems
and adhesins [3,10-14]. The capsule is one of the most
important virulence determinants, protecting against
serum bactericidal activity, antimicrobial peptides and
phagocytosis [11,15-18]. At least 77 capsular (K) types
can be distinguished, but types K1 and K2 are prominent
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by their virulence in murine models of infection [19-21]
and by their epidemiological prevalence [9,18,21,22]. How-
ever, not all K1/K2-type strains are necessarily virulent, as
distinct clonal groups of K1 and K2 differ sharply by their
virulence [23]. Reference strain Kp52.145 (derived from
B5055, the reference strain of serotype K2) is a highly viru-
lent strain from which important virulence factors, includ-
ing the large virulence plasmid harboring the regulator
of mucoid phenotype (rmpA) and the aerobactin clus-
ter, were identified [10,11,21]. Even though a virulence
plasmid-cured strain is less virulent than the parental
strain, it remained more virulent than other isolates that
do not harbor this plasmid [21], showing that factors other
than capsule overexpression and aerobactin account for
the higher pathogenesis of this strain. Therefore, although
known virulence factors are certainly crucial for bacterial
survival, protection and interaction with the host, putative
new virulence factors that could subvert host cell physi-
ology and response remain yet to be identified.
Comparative genomics of pathogenic and non-pathogenic
strains is a powerful approach to identify putative viru-
lence genes. Several draft or complete genomes of clinical
isolates of K. pneumoniae have been published so far, but
only the virulent serotype K1 strain NTUH-K2044 [24]
has been described in detail. In order to identify new K.
pneumoniae K2 virulence factors, we sequenced the
genome of the virulent strain Kp52.145, as well as two
additional strains of low virulence, SB2390 (serotype K2)
and SB3193 (serotype K1). By comparing these three novel
genomes to the publicly available genomes of the viru-
lent K1 strain NTUH-K2044 and reference strain MGH
78578, we identified in Kp52.145 putative virulence genes
and analyzed their distribution within a diverse collec-
tion of K. pneumoniae strains. We demonstrate that a
gene coding for a phospholipase D family protein (PLD1),
located within a type VI secretion system locus, is
expressed in vivo, is involved in controlling bacterial mem-
brane lipid composition, and is a new virulence factor.
Results and Discussion
Genome assembly and annotation
The genomes of Kp52.145, SB2390 and SB3193 were
sequenced by a combination of 454 and Illumina tech-
nologies using single and paired-end libraries. Finishing
efforts resulted in the complete genome sequence of
K. pneumoniae Kp52.145 (one chromosome + two plas-
mids), comprising 5.45 Mbp and 5,314 protein coding genes
(Figure 1). SB2390 and SB3193 genomes were assembled in
11 and 17 scaffolds, respectively. The GC% of these three ge-
nomes ranged from 55.6% to 56.7%. The general features
of the K. pneumoniae sequenced genomes are summa-
rized in Table 1.
Because Kp52.145 is a highly virulent strain, our analyses
were focused on comparing its genome with the genomes
of K. pneumoniae strains SB2390, SB3193, NTUH-K2044
and MGH78578. According to SEED subsystems annota-
tions [25], about 60% of protein-coding genes for each
K. pneumoniae genome had predicted functions. More
specifically, the largest percentage of annotated genes is in-
volved in the metabolism of carbohydrates (approximately
20%), of amino acids and their derivatives (approximately
10%) and of cofactors, vitamins and prosthetic groups
(approximately 8%) [see Additional file 1].
Common genome
To define the common genome of the five strains, we
used stringent BlastClust parameters of at least 90%
identity and at least 80% coverage. This analysis identified
3,587 coding sequences common to the five genomes. The
majority of proteins are involved in metabolic processes,
such as energy metabolism and transporters, supporting
the general concept that the core genome encompasses
essential functions required for survival of the micro-
organism. The K. pneumoniae core genome comprised
several sets of genes whose functions are related to bacter-
ial survival in the environment or interaction with its host,
and possibly virulence. This was the case, for example, of
genes involved in quorum-sensing and biofilm formation,
adhesins, and secretion systems, for which examples are
detailed below.
Genes encoding for autoinducer-2 and type III fimbria,
involved in biofilm formation in K. pneumoniae [26-28],
were present in all sequenced strains. In addition, genes
coding for synthesis and transport of the poly-β-1,6-N-
acetyl-D-glucosamine (PGA) adhesin (KpST66_4915 to
KpST66_4918 in Kp52.145 genome) which is required for
the structural stability of Escherichia coli biofilms [29],
and YidE (KpST66_0019), which mediates the hyperad-
herence phenotype of E. coli [30], were also found in the
core genome of K. pneumoniae strains.
Moreover, the five K. pneumoniae genomes con-
tained the genes barA/uvrY (respectively KPST66_0986
and KpST66_3517) and ycjX/ycjF (KpST66_2441 and
KpST66_2442) that may be involved in bacterial fitness
and virulence. The two-component system BarA/UvrY
(KpST66_3517 and KpST66_0986 in Kp52.145 genome)
contributes to biofilm formation in Salmonella enterica
and is a virulence determinant of urinary tract E. coli in-
fections [31,32]. The E. coli YcjF protein is expressed in a
septicemia murine model of infection in which the ycjF
mutant is attenuated, thus suggesting its implication in
the in vivo survival/multiplication of the bacteria [33].
Several putative secretion systems were identified as
part of the common genome of the K. pneumoniae strains,
including one type I secretion system (T1SS) and one
type II secretion system (T2SS). T2SS is composed of
the pullulanase related genes pulA-O that are involved in
the pathogenesis of several bacteria [34,35]. Streptococcus
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Figure 1 K. pneumoniae Kp52.145 genome. A) Chromosome representation: Outermost layers in gray indicate the position of positive and
negative strand CDSs. tRNAs are represented in green, while the four virulence-related genomic islands (GI) are in red, the locus coding for
anaerobic metabolism in orange, the T6SS gene clusters in blue and capsular synthesis region in yellow. Inner circle represents G + C%.
Detail of the T6SS locus III region containing the putative phospholipase (pld1 gene) (orange) and sel1 (pink) genes is shown enlarged.
B) Plasmids representation: plasmid maintenance genes and IS sequences are shown in blue, proteins with unknown functions in gray,
known functions in green, toxin-antitoxin systems in yellow and rmpA in red. CDSs, coding sequences.
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pyogenes PulA binds to host lung glycogen leading to a
strong interaction with alveolar type II cells [36]. Similarly,
the alpha-amylase AmyA degrades glycogen into cyclic
maltodextrins, which increases the transepithelial trans-
location of Streptococcus [37]. Both amyA and pulA-O
genes are encoded in K. pneumoniae genomes, but their
functions in this bacterium remain to be characterized.
Type VI secretion system (T6SS) putative genes were lo-
cated in at least three different loci of the K. pneumoniae
genomes, in accordance with a previous in-silico study
[38]. T6SS clusters are usually found within pathogenicity
islands or on chromosomal regions presenting virulence
or host survival biases. Additionally, T6SS has been sug-
gested to assist colonization and infection. Indeed, in a
screen that identified K. pneumoniae mutants failing to
colonize mice [39], two of them were mutants in genes
coding for proteins annotated as hypothetical, that have
been subsequently re-annotated as T6SS proteins [38].
Type III secretion systems were not found in Klebsiella,
but type IV secretion systems, possibly corresponding to
conjugation apparatus, were present only in some strains
(Kp52.145, SB2390 and NTUH-K2044) (Table 2).
Furthermore, the core genome presented a large gen-
omic region located between gly-tRNA and phe-tRNA loci
in Kp52.145 genome, containing frdABCD genes coding
for the fumarate reductase enzymatic complex respon-
sible for fumarate respiration under anaerobic growth
of bacteria. This complex is a virulence determinant for
Helicobacter pylori, Mycobacterium tuberculosis, Actino-
bacillus pleuropneumoniae and S. enterica, as mutants on
these genes are attenuated [40-43]. The ability to grow an-
aerobically allows bacterial pathogens to persist in host
tissues, including in the lungs. Curiously, this genomic
locus encoded in K. pneumoniae at least one more
protein involved in anaerobic metabolism, the anaer-
obic C4-dicarboxylate transporter DcuA (KpST66_4904),
supporting the idea that this GI provides K. pneumoniae
advantages to grow under anaerobic conditions, possibly
favoring infection. Additional proteins that might be
involved in bacterial fitness to environmental stress
conditions were encoded in this region. For instance,
the putative small multidrug resistance protein SugE
(KpST66_4882) has been shown to regulate biofilm for-
mation and capsule expression [44]. A lipocalin-2 bacterial
protein Bcl (KpST66_4881) is also encoded in this island
of the genome. Eukaryotic lipocalins are small extracel-
lular proteins that bind hydrophobic ligands and fulfill
numerous biological functions including regulation of
Table 1 General features of the K. pneumoniae genomes analyzed
K-type Strain bank ID Scaffolds Size (Mb) % GC Total PCG rRNA operons tRNA genes % coding Plasmids Reference
K2 3341/Kp52.145 3 5.45 56.4 5,314 8 85 88 2 This manuscript
K2 2390 11 5.62 56.74 5,367 6 77 86.8 ? This manuscript
K1 3193 16 5.01 55.6 4,793 10 73 92 ? This manuscript
K1 NTUH (ST23) 2 5.24 57.6 4,992 19 76 89 1 Wu et al. [63]
K5 MGH (SB107) 6 5.31 57 4,776 10 56 85 5 (NC_009648)
The three genomes sequenced in this study are compared to strains NTUH and MGH, previously published. PCG, protein coding genes.
Table 2 Distribution of virulence-related factors among K. pneumoniae genomes analyzed
Virulence-factor SB3341 SB2390 SB3193 NTUH MGH Functional role
rmpA ++ - - ++ - Regulator of capsule expression
Aerobactin + - - + - Siderophore
Enterobactin + + + + + Siderophore
Yersiniabactin + + + + - Siderophore
Colibactin + - - - - Genotoxin
T4SS (virB) + + - + - Conjugative machinery/protein secretion
T2SS + + + + + Protein secretion
T6SS + + + + + Protein secretion
Pld-family + - - - - Lipid metabolism
Sel1 lipoproteins + - - - - Unknown
cOMP + - - - - Putative cytotoxin
Igg-like + - - - - Binding to extra cellular matrix compounds
SEFIR-domain + - - - - Potentially hijack IL17R signaling pathways
Bcl + + - + + Binding to hydrophobic ligands / putative
regulation of homeostasis and immunity
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cellular homeostasis and immunity and are regulators
of antibacterial defense [45]. Lipocalin2 is for instance
a siderophore scavenger for several bacteria, including
K. pneumoniae [46], as well as a negative regulator of
inflammatory response during Streptococcus pneumoniae
pneumonia [47]. However, the role of bacterial lipocalins
is not yet known.
Finally, a phosphatidylserine decarboxylase (KpST66_4873)
might be important for the integrity of the bacterial
membrane composition, as phospholipid biosynthetic
pathways play crucial roles in the virulence of several
pathogens [48,49].
Accessory genome
The accessory genome (genes absent in at least one of
the five strains) included a large number of specific cod-
ing sequences (CDSs): 743 genes were found only in
Kp52.145, 608 in NTUH-K2044, 806 in SB3193, 635 in
SB2390 and 488 in MGH78578. About 50% of these
genes code for hypothetical proteins or proteins of un-
known function. The distribution of the putative virulence-
related genes of K. pneumoniae among the sequenced
strains is summarized in Table 2. The specific regions or
genes of Kp52.145 are detailed below.
Kp52.145 plasmids
Strain Kp52.145 possessed two plasmids (Figure 1B). The
first plasmid of 121 Kb carried the aerobactin cluster and
the regulator of mucoid phenotype rmpA genes. The pres-
ence of this plasmid was previously correlated with the
virulence of K. pneumoniae K1 and K2 isolates [21,50].
Additionally, a strain cured from this plasmid showed a
6 × 104-fold reduction in virulence, establishing the
link between this plasmid and bacterial virulence [21].
In addition to aerobactin and rmpA, this plasmid con-
tained genes coding for F-pilin, purine metabolism,
insertion sequences and proteins of unknown functions.
Kp52.145 also carried a second, previously non-described,
plasmid of about 90 Kb. Interestingly, it contained rmpA2,
a homologue of the regulator of mucoid phenotype
rmpA, which seems to be involved in capsule expression
regulation [51,52]. F-pilin genes, a subtilisin-related serine
protease, an AAA+ATPase, the UV protection system
UmuD/UmuC and the genes encoding the toxin-antitoxin
systems RelE/orf4 and VagD/VagC (Figure 1B) were also
found on this plasmid. However, the potential role of these
genes in virulence remains to be investigated.
Genomic islands identified in the genome of strain
Kp52.145
In addition to the capsule synthesis operon and the iron-
acquisition systems (yellow and orange boxes in Figure 1A,
respectively), known to be involved in K. pneumoniae
virulence, four additional regions of the Kp52.145 genome
presented several characteristics of pathogenicity islands
(red boxes, Figure 1A). These regions are defined by a
different GC content in comparison to the average of
the genome, represented large chromosomal regions
(often > 30 Kb), were associated with tRNA genes or
with the presence of insertion sequences, integrases and
transposases, and were present in pathogenic strains while
less frequent in less-virulent strains [53,54]. The four
GIs present in the Kp52.145 genome were present or
partially present in NTUH, but none of them was present
in SB2390, SB3193 and MGH 78578, indicating that their
occurrence is specific to pathogenic genomes. Figure 2
shows the four GIs identified, highlighting the puta-
tive virulence related genes.
Genomic island 1 (GI-1): ICE-Kp1-like region
The largest GI found in the Kp52.145 genome comprised
133,679 bp, presented a GC content of 52%, was inserted
in an asn-tRNA locus and encoded 92 CDSs (Figure 2A).
Most of the protein-coding genes found in this region
were described as part of the IceKpI GI of NTUH-K2044
[55,56], although several differences were found. Kp52.145
GI-I begins at asn tRNA locus followed by several unchar-
acterized proteins and insertion sequence elements. GI-I
coded for the synthesis of two polyketide/nonribosomal
peptides (yersiniabactin and colibactin) and for the conju-
gative transfer machinery (T4SS) that allows horizontal
transfer of the island [56]. In contrast to the previous
description of IceKpI [56], the Kp52.145_GI-I carried
colibactin and did not contain the region coding for vagC-
vagD, iroN-iroB-iroC-iroD and rmpA genes which are
carried only by the 121 kB plasmid in Kp52.145.
Genomic island 2 (GI-II)
We describe here a novel GI (GI-II). It is a 29,829 bp is-
land, with a GC content of 49% and coding for 28 CDSs
which is inserted in a leu-tRNA locus (Figure 2B). Poten-
tial pathogenesis-related genes coded for a putative cyto-
toxic outer membrane protein (cOMP, KpST66_4736)
and a polyamine ABC transport system (KpST66_4729 to
KpST66_4732). cOMP closest known homologue (34%
identity) was a Plesiomonas shigelloides predominant viru-
lence factor proposed to trigger cell death in host cells
following infection [57]. Polyamine biosynthesis and
transport mechanisms were intricately linked to fitness,
survival, biofilm formation and pathogenesis, for instance
in S. pneumoniae and Yersinia pestis [58,59]. Additionally,
this GI encoded a 4-phytase gene (KpST66_4736), ugpQ3
(KpST66_4728) and xylA, xynT, xynB, xylR (KpST66_4724
to KpST66_4727) that are involved in xylose metabolism.
Genomic island 3 (GI-III)
The third GI is characterized by a 49,657 bp region pre-
senting a G + C content of 51% and contained 66 CDSs,
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most of them coding for phage structural proteins
(Figure 2C). This GI included genes coding for pro-
teins with homologues that were shown to play a role
in bacterial adhesion and immune system escape [60-62].
These proteins encoded for an immunoglobulin domain-
containing protein (KpST66_1506), a peptidase S24-like
protein (KpST66_1511), two HNH family endonucleases
(KpST66_1468 and 1486) and an exonuclease (locus
1464).
Genomic island 4 (GI-IV)
The forth island (GI-IV) was mainly comprised of phage-
related genes. Among the 42 CDSs encoded within this
genomic region, one gene coded for a SEFIR-domain
containing protein (KpST66_1945; Figure 2D). A SEFIR
domain is usually found in IL17 receptors and SEF pro-
teins, acting in eukaryotes signaling pathways. Very little
is known about prokaryotic SEFIR-containing proteins.
Structural analyses suggested that these bacterial SEFIR
domains share structural and electrostatic similarity with
their mammalian homologues and, thereby, could po-
tentially subvert host immunity by hijacking the IL17R
signaling pathways [63]. Notably, local production of
IL-17 is a significant factor in effective host defense
against Gram-negative bacteria, including K. pneumoniae
[64]. Therefore, further studies are required to elucidate
whether KpST66_1945 is implicated in K. pneumoniae
pathogenesis.
Distribution of GIs among K. pneumoniae strains
To investigate the distribution of the described GIs in
K. pneumoniae, the presence of the putative virulence-
related genes was searched using BlastN in 171 genomes,
including 119 publicly available and 52 unpublished ge-
nomes (Bialek-Davenet, Brisse et al., unpublished work)
representing 47 different sequence types (STs). Whereas
the SEFIR-domain containing protein gene of GI-IV was
only found in two (1.2%) isolates of sequence type ST15,
the three other GIs described herein were more distrib-
uted among K. pneumoniae isolates (Table 3). GI-II genes
were present in a total of 11 (6.4%) isolates, most of which
belonged to ST375, ST65 and ST25, which were associ-
ated with severe infections caused by isolates of capsular
serotype K2 [9,65]. The genes of GI-II were always found
in synteny. GI-III genes were observed in only seven
(4.1%) isolates dispersed in several unrelated STs. The dis-
tribution of the ICEKpI element (similar to GI-I) has been
previously analyzed [55].
T6SS locus III insertion
Recently, three different T6SS loci were defined in K.
pneumoniae [38]. Within these loci, three putative valine-
glycine repeat (Vgr) proteins and two hemolysin-coregulated
proteins (Hcp) were described as potential effector proteins,
through their sequence similarities to Vibrio cholerae and
Pseudomonas aeruginosa effector proteins [65-68]. Ac-
cordingly, the Kp52.145 genome also presented three con-
served T6SS loci syntenic to those previously described.
The first two loci were identical in composition and orien-
tation to the previously described ones. The third one,
locus III, had conservation of adjacency limited to the
imcF/impG/impH and impJ/ompA/vgrG gene clusters, as
a region with nine genes was inserted between these two
clusters. This insertion encoded for one hypothetical
protein, five putative Sel-1 repeat containing lipopro-
teins and three putative phospholipase D family proteins
Table 3 Prevalence of the genomic islands among K. pneumoniae isolates
Genomic island Virulence-related features Prevalence (%) Remarkable STs
GI-I Colibaction 3.5a -
Yersiniabactin
GI-II cOMP 5.8 3775,65,25
4-phytase
GI-III Igg-like 8.1 Dispersed
Exonuclease 57.6 375,65
GI-IV Sefir-domain 1.7 -
T6SS insertion PLD1 7.0 380,35
Sel 1 7.0 380,35
aaccording to ref. [55]. Prevalence of virulence-related features encoded in GI-II, GI-III, GI-IV and T6SS insertion was based on >90% identity and >50% coverage in
the length of the genes, using a database of 171 Klebsiella genomes representative of 47 different STs. STs, sequence types.
(See figure on previous page.)
Figure 2 Genomic islands (GIs) identified in the genome of Kp52.145. Positive and negative strand CDSs are represented in gray. Putative
virulence related genes are highlighted in different colors. The size of each GI is given in kb. Panel A: GI-I, B: GI-II, C: GI-III and D: GI-IV. CDS,
coding sequences.
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(Figure 1A). Flanking sequences suggesting how this region
was inserted were not found.
Sel1 lipoproteins are poorly characterized and there
was no evidence for their function in K. pneumoniae,
but they are essential in Legionella pneumophila for inva-
sion of host cells where they influence vacuolar trafficking
of bacteria [69]. The three open reading frames encod-
ing putative phospholipase D proteins in strain Kp52.145
encoded one full length protein (KpST66_3368, 623 ami-
noacids), one C-terminal region (KpST66_3371, 187 aa) and
one N-terminal region (KpST66_3372, 317 aa). Phospholip-
ase D family proteins have been described as important
for host cell invasion, bacterial dissemination and dis-
ease progression [70-73]. The bacterial phospholipase
D family comprises at least four classes of proteins with
distinct functions: true phospholipase D, cardiolipin syn-
thase, phosphatidylserine synthase and endonuclease [74].
Full length K. pneumoniae PLD1 and its closest homologs
all presented the conserved motif HXK(X)4D and a serine
or threonine approximately eight residues after asparagine
(Figure 3), but no other conserved domain was described
in each family, thus making it difficult to infer protein
function only by sequence analysis.
In order to obtain evidence that the product of
these three genes coding either for full length or partial
PLD-family proteins are important for bacterial survival
in vivo, we checked by RT-PCR for their mRNA expres-
sion. We observed that these genes are expressed
both in bacteria grown for four hours in Trypto Casein
Soy broth (GTCS) medium, as well as in the lungs of
mice infected for 24 hours (data not shown). These
results prompted us to further check for a putative
involvement of the full length PLD gene, called pld1, on
K. pneumoniae virulence.
Involvement of the phospholipase D family protein gene
pld1 in KP 52.145 virulence
As PLD-family proteins have been shown to be involved in
virulence [75-77], we decided to characterize the role of
the full length PLD1 protein. We first tested a pld mutant
strain in a K. pneumoniae murine model. Mice were in-
fected intranasally with 108 of either the wild-type bacteria,
a pld1 mutant, or the mutant strain complemented with a
plasmid expressing the putative PLD1 protein (pPLD), and
their survival was monitored for seven days. Interestingly,
the mutant strain appeared avirulent in a mouse model of
acute pneumonia while mice infected with the wild-type
and the complemented strain succumbed in less than one
week (Figure 4). However, the wild-type, the mutant and
the complemented mutant strains grew equally well in
Luria-Bertani broth (LB) broth (data not shown). These
results indicated that the pld1 mutant was strongly attenu-
ated in vivo, thus showing an important role for PLD1 in
virulence.
To analyze the frequency and clonal distribution of
the pld1 gene in K. pneumoniae, the 171 genomes were
analyzed using BlastN. We observed that besides ST66,
represented by strain Kp52.145, pld1 was present in
10 strains (6.4%) belonging to ST380, ST679, ST67
(K. pneumoniae subsp. rhinoscleromatis) and ST35, but
in none of the other isolates. It is interesting to note that
ST380 was associated with severe K. pneumoniae infections
[9,65] and that K. pneumoniae subsp. rhinoscleromatis is
the only Klebsiella strain to be able to survive intracellularly
in macrophages [78].
Functional characterization of PLD1
In order to demonstrate the phospholipase activity of
PLD1 and characterize its involvement in lipid metabol-
ism, the lipid composition of wild-type and mutant strains
was analyzed by thin-layer chromatography (TLC). A re-
markable lipid spot was absent from the pld1 mutant in
comparison with the complemented strain, suggesting
that the putative PLD1 is involved in lipid metabolism
[see Additional file 1]. To reinforce this result, a plasmid
carrying the pld1 gene was inserted into E. coli strain SD9
[79]. This strain is deficient in phosphatidylserine and car-
diolipin, thus presenting a simpler lipid composition than
its parental strain and Kp52.145. Lipid profiles of SD9 and
complemented strains had a different lipid compos-
ition. Notably, the PLD1-expressing strain contained an
additional lipid spot in comparison to the SD9 strain,
suggesting that PLD1 is responsible for this difference
(Figure 5A). SD9 wild-type strain also presented an extra
lipid spot in comparison to the PLD1-expressing strain,
possibly representing the PLD1 substrate (Figure 5A).
Densitometric analysis of iodine-stained lipids on TLC
plates revealed that this lipid spot corresponded to 21% of
the total amount of lipids in SD9 strain, but only 6% of
SD9 complemented with a plasmid expressing pld1. Mass
spectrometry (MS) analysis of total lipid extract was car-
ried out to identify such lipid. Comparing lipid profiles by
MS, we found a lipid of mass 788.4 present only in the
PLD1-deficient strain (Figure 5B) and identified it as phos-
phatidyl glycerol (PG) using the LipidMaps database.
As mentioned above, the bacterial PLD-family proteins
can be classified in four subfamilies. One of them, the
cardiolipin synthase is able to convert two PG molecules
into glycerol and cardiolipin, or to catalyze the opposite
reaction, leading to PG formation [80]. Our results
suggest that PLD1 belongs to the cardiolipin synthase
subfamily and that it plays a role in balancing the PG
and cardiolipin content.
It has been shown that humans and mice with bacterial
pneumonia have markedly elevated amounts of cardiolipin
in lung fluid and that it impairs surfactant function, lung
mechanics, modulation of cell survival and cytokine net-
works and lung consolidation [81].
Lery et al. BMC Biology 2014, 12:41 Page 8 of 15
http://www.biomedcentral.com/1741-7007/12/41
Figure 3 Sequence alignment of Kp52.145 (Kp) PLD1 and its closest related sequences: putative phospholipase D family protein from
Pseudomonas syringae (PS) and cardiolipin synthases from P. putida (PP), Staphylococcus aureus (SA), Bacilus subtilis (BS) and E. coli (EC).
The rectangles indicate the phospholipase D active site regions and the asterisk points to the corresponding transposon insertion site in pld1
mutant strain.
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There is evidence that bacteria are able to adjust their
relative concentrations of phosphatidylethanolamine and
PGs when subjected to environmental stresses. Such an
alteration in headgroup composition seems to be a
means for changing membrane permeability and, hence,
preserving stability [82]. Therefore, we hypothesize that
PLD1 alters the membrane composition and charge, af-
fecting bacterial interaction with the host environment.
Recently, Russel el. al. demonstrated that diverse phospho-
lipase proteins encoded within the T6SS loci of several
prokaryotic genomes are antibacterial effectors, conferring
competitive advantages on the donor strain during inter-
bacterial interactions [83]. These proteins are generally
designated as ‘T6SS Lipase Effectors’ (Tle) and classified
in five sub-families, according to the sequence conserva-
tion and number of catalytic motifs present. Kp52.145
PLD-family protein could be considered a Tle5 member,
as it presents two conserved HxKxxxxD motifs. However,
in the Kp52.145 genome we did not identify any gene
similar to the cognate immunity genes - a hallmark of the
genomic islands described by Russel et al. Moreover, we
did not observe such an antibacterial effect of Kp52.145 or
its PLD1 mutant strain upon competition with E. coli [see
Additional file 1]. These results showed that pld1 is impli-
cated in virulence without being an anti-bacterial factor
and is, so far, unique.
Conclusions
This study presents a comparative analysis of the complete
genome sequence of the high virulence reference strain
Kp52.145, a derivative of the K2 reference strain B5055. It
revealed five genomic regions possibly involved in bacterial
virulence. One gene, pld1, was shown to be involved in
virulence in a mouse model of pneumonia and revealed a
novel implication of lipid metabolism in K. pneumoniae
pathogenesis. Future analysis of additional putative viru-
lence factors such as Sel1 lipoproteins, VgrG, Hcp, Bcl,
cOMP and Sefir-domain containing protein are required
for a comprehensive understanding of K. pneumoniae core
virulence genes.
Methods
Selection of isolates for genome sequencing/bacterial
strains
Strain Kp25.145 (a derivative of B5055, the reference
strain of serotype K2) is a laboratory strain used to study
K. pneumoniae pathogenesis [11,21] and was chosen as the
focus of this work. SB2390 (cur15505, isolated in Curaçao,
2002, urinary tract infection; belongs to ST14) and SB3193
(IPEUC-744, isolated from a metritis case in a mare, 1981
in France; belonging to ST82) [23] are non-virulent strains
that were sequenced to allow the comparison between viru-
lent and non-virulent strains.
The pld1 transposon mutant was isolated by Anna
Tomas and Jose Bengoecheoa during a screen of a K.
pneumoniae mutant library made by Tn5 transposon in-
sertion (manuscript in preparation). In this mutant, the
transposon was inserted at position 1,625 of pld1 gene.
The complementation of the mutant strain was achieved
through bacterial transformation using electrocompe-
tent cells and a plasmid carrying pld1 gene. pld1
gene was amplified by PCR and cloned at the multiple
Figure 4 PLD1 involvement in K. pneumoniae virulence. Mice survival after infection with K. pneumoniae Kp52.145 wild-type, pld1 mutant and
complemented strains. Data are representative of seven mice per group from two independent experiments. Standard deviation is shown. PLD,
phospholipase D.
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Figure 5 (See legend on next page.)
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cloning site of puc18 plasmid. Cloning was confirmed by
DNA sequencing.
Genome sequencing and assembly
K. pneumoniae strains were sequenced using a combin-
ation of 454 and Illumina reads. Single and paired-end
454 reads with an average of 400 nucleotides were as-
sembled into contigs and scaffolds by Newbler. Illumina
reads of about 76 or 36 nucleotides were aligned to scaf-
folds in order to confirm and correct possible homo-
polymer errors in the 454 reads. Coverage was as follows:
Kp52.145 genome: 170 X using GAIIX (76 nt) + 13.8 X
using MP titanium + 18 X using SR titanium; SB2390
genome: 81 X using GAIIX (36 nt) + 6.4 X using MP
titanium + 22 X using SR titanium; SB3193 genome:
209 X using GAIIX (76 nt) + 5.4 X using MP titan-
ium + 20 X using SR titanium.
Following the primary assembly of the genomes, an
in silico finishing approach, based on the methods de-
scribed by Pop et al. [84], was performed in order to
identify small and identical repeats on the genomes. In
such cases and without high quality bases discrepancies,
the contigs containing the small repeats were manually
duplicated and added to the assembly.
Scaffolds were aligned to experimentally determined
BglII optical maps generated by OpGen company from
purified chromosomal DNA, using MapSolver version 3.1
software. Such alignments were used to check for the qual-
ity of the assemblies. Additionally, specific pairs of primers
were designed in order to close all remaining gaps. PCR
products were purified in NucleoFast 96 plates (Macherey
Nagel, Düren, Germany) and aliquots were used for se-
quencing reactions with the BigDye Terminator Cycle Se-
quencing Ready reaction Kit (Applied Biosystems, Foster
City, CA, USA) on a ABI Prism 3730XL DNA Analyzer
(Applied Biosystems). The resulting sequences were added
to the previous assembly using Phred/Phrap/Consed.
The sequences of K. pneumoniae genomes have been de-
posited to the European Nucleotide Archive and are access-
ible under the accession numbers: FO834904, FO834905
and FO834906 (strain Kp52.145), CCBO00000000 (strain
SB2390) and CCCQ000000000 (strain SB3193).
Functional annotation of genomes
In order to gain functional insights about the genome
sequences, protein-coding genes were predicted and
annotated using the CAAT-box genome browser [85],
using a combination of GeneMark predictions and Blastx
results against the Uniprot database. All the putative open
reading frames (ORF) longer than 120 nucleotides pre-
senting similarity to sequences of the Uniprot database or
positive GeneMark result were considered for further ana-
lysis. The final set of CDSs underwent a manual annota-
tion process based on description of similarity. Pfam and
COG database searches, as well as SignalP, TMHMM and
PredTMBB predictions were performed to improve the
degree of annotation confidence, if necessary. CDSs were
described as ‘highly similar to’, ‘similar to’ or ‘weakly simi-
lar to’ if they presented more than 70%, between 50% and
69% or less than 50% similarity to the protein hit se-
quence. Additionally, information on partial homology
was included. The start codon for each CDS was automat-
ically chosen and manually validated, based on a combin-
ation of GeneMark results and Blast alignments. RAST
was used to classify proteins in functional categories.
Structural RNAs were searched using tRNAscan.
The common genome of the five strains was determined
using the BlastClust algorithm [86] using minimum pa-
rameters of 90% identity and 80% length coverage for pro-
teins to be included in the same cluster.
RT-PCR
Lungs of control or Kp52.145-infected mice were homog-
enized in cold TRI reagent (Sigma, Gillingham, Dorset,
UK) using a Precellys lysing kit (Precellys, Saint Quentin
en Yvelines, France). Total lung and bacterial mRNAs
were extracted according to the manufacturer’s instruc-
tions. RNA (2 μg) was reversed transcribed in cDNA using
Superscript II enzyme (Invitrogen, Foster City, CA, USA).
Aliquots were used in PCR reactions using specific
primers [see Additional file 1].
Animal experiments
BALB/cJ mice were purchased from Janvier (Le Genest
St. Isle, France). Mice were housed under standard con-
ditions of feeding, light and temperature with access to
food and water ad libidium. Experiments were per-
formed according to the national and Institut Pasteur
guidelines for laboratory animal experiments. Protocols
were approved by the Institut Pasteur animal care and
use committee (protocol 05–59) and the Direction des
Services Vétérinaire de Paris (permit 75–713 to RT).
Six- to eight-week-old mice were anesthetized with ace-
promazine (Calmivet, 1.5 mg/kg, Vetoquinol, Lure,
France). and ketamine (Imalgene, 31.25 mg/kg, Merial,
Lyon, France). and then infected intranasally with 20 μl
(See figure on previous page.)
Figure 5 PLD1 involvement in lipids metabolism. A) TLC lipid profiles of E. coli strain SD9 and SD9 + pPLD. Red circle indicates phosphatidyl
glycerol. Blue circle represents the lipid present specifically upon pld1 expression. B) Mass spectrometry profiles of E. coli strain SD9 and SD9 + pPLD
lipids. The red arrow points to m/z 789.4 exclusively found in wild-type strain. TLC, thin-layer chromatography.
Lery et al. BMC Biology 2014, 12:41 Page 12 of 15
http://www.biomedcentral.com/1741-7007/12/41
bacterial suspension. The virulence of K. pneumoniae
strains was tested on six-week-old BALB/c mice, as pre-
viously described [23]. Seven mice per test condition
were infected with 108 bacteria. Mice were followed
every day for one week. Experiments were performed at
least twice.
Thin-layer chromatography and mass spectrometry of
lipids
Bacterial lipids were extracted by the method of Bligh
and Dyer [87]. Briefly, bacterial stationary-phase cultures
were concentrated 10 times and mixed with chloroform:
methanol. After centrifugation at 1,000 rpm for five mi-
nutes, the organic phase was recovered. Lipid profiles
were analyzed by two-dimensional TLC using TLC Silica
gel 60 F254 plates (Merck, Whitehouse Station, NJ,
USA). as the stationary phase and a chloroform 9:1
methanol mixture as the mobile phase in both dimen-
sions. Staining was performed by iodine vapor. TLC
calibrated images were aquired in ImageScanner using
LabScan v5.0 software. The relative intensity of each
spot was calculated in ImageMaster two-dimensional
Platinum v7.0 software. Alternatively, lipid extracts were
analyzed by MS and MS/MS in an ESI-Q-Tof Micro
(Waters), in positive ion mode. Resolution was typically
lower than 10 ppm.
Anti-bacterial competition assays
Competition assays were performed as previously de-
scribed [88]. Briefly, K. pneumoniae Kp52.145 or its pld1
mutant cells grown overnight on an agar plate were re-
suspended in LB, normalized to OD600 of 0.5 and mixed
at a ratio of 5:1 with a spontaneous nalidixic acid (nal)
resistant mutant strain of E. coli MG1655. The mixture
was incubated for four hours on a prewarmed agar plate.
Recovered cells were plated out on antibiotic selective
media and viable cells were reported as the total number
recovered per co-culture spot. Serratia marcescens DB10
was used as a positive control.
Additional file
Additional file 1: 1) Distribution of K. pneumoniae Kp52.145 genes,
according to RAST categories. Each functional category is represented
in a different color. The total number of genes per category is shown.
2) pld PCR assay. A collection of 42 virulent and non virulent clones was
screened by PCR for pld gene. Strains containing pld gene are indicated
by (+) and the absence of pld gene is (-). 3) TLC lipid profiles of
K. pneumoniae Kp52.145 wild-type (left panel) and pld mutant strains
(right panel). Black circles indicate differentially expressed lipids.
4) Bacterial competition assay. Anti-bacterial activity was measured
as the number of E. coli cells recovered after the co-culture with
K. pneumoniae Kp52.145 wild-type and pld mutant strains. S. marcesens was
used as a positive control strain. 5) List of primers used for RT-PCR analysis.
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